Skip to main content
Top
Published in: Clinical Rheumatology 10/2020

01-10-2020 | ANCA-Associated Vasculitis | Clinical Image

Diplopia and ocular pain due to orbital myositis

Authors: Rosa I. Arvizu-Rivera, Rita A. Pineda-Sic, Jesus Alberto Cardenas-de la Garza, Dionicio A. Galarza-Delgado, Miguel A. Villarreal-Alarcon

Published in: Clinical Rheumatology | Issue 10/2020

Login to get access

Excerpt

A 19-year-old man presented to the emergency department because of sudden onset of diplopia and ocular pain. He reported a 1-week history of malaise and headache. He denied travels or rash. Physical examination revealed ptosis and limited and painful abduction of the right eye. Pupillary light reflexes and dilated fundus examination were normal. Complete blood count, biochemical profile, erythrocyte sedimentation rate, C-reactive protein, and thyroid function tests were within normal limits. Antinuclear antibodies, anti-neutrophil cytoplasmic antibodies (ANCA), anti-myeloperoxidase, and anti-proteinase 3 were negative. Fat suppression T1-weighted magnetic resonance imaging (MRI) showed right lateral rectus muscle enlargement with contrast enhancement, and tendinopathy (Fig. 1).
Metadata
Title
Diplopia and ocular pain due to orbital myositis
Authors
Rosa I. Arvizu-Rivera
Rita A. Pineda-Sic
Jesus Alberto Cardenas-de la Garza
Dionicio A. Galarza-Delgado
Miguel A. Villarreal-Alarcon
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 10/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05147-8

Other articles of this Issue 10/2020

Clinical Rheumatology 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.